OYSTER POINT PHARMA, INC. (OYST) Social Stream



OYSTER POINT PHARMA, INC. (OYST): $4.42

0.09 (+2.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add OYST to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

Featured Post From StockTwits About OYST

$OYST just listened to the conference call. As always, I’m pleased with how organized and aggressive management has been towards the launch. I know I’ve already been contacted by a sales rep at my ophthalmology clinic. Again, the current valuation on this company makes no sense. They have $150 million cash on hand, burn about 70-80 million a year, are about to get $17.5 million from China soon. they also just secured a $125 million credit line to fund the launch, so hopefully no more secondaries any time soon. Their market cap is in the $360 million range. So a likely to soon be approved novel dry eye medicine is only worth $200 million? Xiidra was bought for $3.5 billion.
AlfredDuffel, published August 6, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4421 seconds.